United States (US) Parkinsons Disease Market (2025-2031) | Trends, Value, Industry, Competitive Landscape, Growth, Segmentation, Outlook, Forecast, Size & Revenue, Companies, Analysis, Share
Market Forecast By Drug Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), By Medical Devices (Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices), By Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, Others), By Distribution Channel (Hospital Pharmacies, Clinics, Retail Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics) And Competitive Landscape
| Product Code: ETC9972883 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- United States (US) Parkinsons Disease Market Outlook
- Market Size of United States (US) Parkinsons Disease Market, 2024
- Forecast of United States (US) Parkinsons Disease Market, 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Revenues & Volume for the Period 2021- 2031
- United States (US) Parkinsons Disease Market Trend Evolution
- United States (US) Parkinsons Disease Market Drivers and Challenges
- United States (US) Parkinsons Disease Price Trends
- United States (US) Parkinsons Disease Porter's Five Forces
- United States (US) Parkinsons Disease Industry Life Cycle
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Drug Class for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Levodopa/Carbidopa for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Dopamine Receptor Agonists for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By MAO-Inhibitors for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By COMT-Inhibitors for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Anticholinergics for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Other Drugs for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Medical Devices for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Deep Brain Stimulation (DBS) Devices for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Route of Administration for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Oral for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Transdermal for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Intestinal Infusion for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Others for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Patient Care Setting for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Hospitals for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
- United States (US) Parkinsons Disease Import Export Trade Statistics
- Market Opportunity Assessment By Drug Class
- Market Opportunity Assessment By Medical Devices
- Market Opportunity Assessment By Route of Administration
- Market Opportunity Assessment By Distribution Channel
- Market Opportunity Assessment By Patient Care Setting
- United States (US) Parkinsons Disease Top Companies Market Share
- United States (US) Parkinsons Disease Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Parkinsons Disease Company Profiles
- United States (US) Parkinsons Disease Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United States (US) Parkinsons Disease Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Parkinsons Disease Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Parkinsons Disease Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Parkinsons Disease Market - Industry Life Cycle |
3.4 United States (US) Parkinsons Disease Market - Porter's Five Forces |
3.5 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 United States (US) Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the United States |
4.2.2 Technological advancements in the treatment of Parkinson's disease |
4.2.3 Growing awareness and early diagnosis initiatives |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease medications and treatments |
4.3.2 Lack of skilled healthcare professionals specializing in Parkinson's disease |
4.3.3 Side effects and limited efficacy of current treatment options |
5 United States (US) Parkinsons Disease Market Trends |
6 United States (US) Parkinsons Disease Market, By Types |
6.1 United States (US) Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 United States (US) Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 United States (US) Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 United States (US) Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 United States (US) Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 United States (US) Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 United States (US) Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 United States (US) Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 United States (US) Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 United States (US) Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 United States (US) Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United States (US) Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 United States (US) Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 United States (US) Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 United States (US) Parkinsons Disease Market Import-Export Trade Statistics |
7.1 United States (US) Parkinsons Disease Market Export to Major Countries |
7.2 United States (US) Parkinsons Disease Market Imports from Major Countries |
8 United States (US) Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of Parkinson's disease diagnosis in the United States |
8.2 Number of clinical trials for new Parkinson's disease treatments |
8.3 Percentage of Parkinson's disease patients receiving timely access to specialist care |
8.4 Adoption rate of telemedicine and digital health solutions for Parkinson's disease management |
9 United States (US) Parkinsons Disease Market - Opportunity Assessment |
9.1 United States (US) Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United States (US) Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 United States (US) Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 United States (US) Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 United States (US) Parkinsons Disease Market - Competitive Landscape |
10.1 United States (US) Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Thought Leadership and Analyst Meet
Our Clients
Related Reports
- Germany Breakfast Food Market (2026-2032) | Industry, Share, Growth, Size, Companies, Value, Analysis, Revenue, Trends, Forecast & Outlook
- Australia Briquette Market (2025-2031) | Growth, Size, Revenue, Forecast, Analysis, Trends, Value, Share, Industry & Companies
- Vietnam System Integrator Market (2025-2031) | Size, Companies, Analysis, Industry, Value, Forecast, Growth, Trends, Revenue & Share
- ASEAN and Thailand Brain Health Supplements Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- ASEAN Bearings Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Europe Flooring Market (2025-2031) | Outlook, Share, Industry, Trends, Forecast, Companies, Revenue, Size, Analysis, Growth & Value
- Saudi Arabia Manlift Market (2025-2031) | Outlook, Size, Growth, Trends, Companies, Industry, Revenue, Value, Share, Forecast & Analysis
- Uganda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Rwanda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Kenya Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
Industry Events and Analyst Meet
Stationery & Paper Expo Saudi Arabia 2026
Kids & Toys Expo Saudi Arabia 2026
Gifts & Homeware Expo Saudi Arabia 2026
Smart Home Expo 2026
Industrial Facilities Management Expo 2025
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
